Scope of the Report:

This report studies the K Cells market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the K Cells market by product type and applications/end industries.

The global K Cells market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of K Cells.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Takeda Pharmaceutical (Japan)

Sorrento Therapeutics Inc. (USA)

NantKwest Inc. (USA)

Bristol-Myers Squibb (USA)

NKT Therapeutics (USA)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Mogamulizumab

Lorvotuzumab Mertansine

Others

Market Segment by Applications, can be divided into

Cancer

Cardiovascular Diseases

Others

Table of Contents

1 K Cells Market Overview

1.1 Product Overview and Scope of K Cells

1.2 Classification of K Cells by Types

1.2.1 Global K Cells Revenue Comparison by Types (2017-2023)

1.2.2 Global K Cells Revenue Market Share by Types in 2017

1.2.3 Mogamulizumab

1.2.4 Lorvotuzumab Mertansine

1.2.5 Others

1.3 Global K Cells Market by Application

1.3.1 Global K Cells Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Cancer

1.3.3 Cardiovascular Diseases

1.3.4 Others

1.4 Global K Cells Market by Regions

1.4.1 Global K Cells Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) K Cells Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) K Cells Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) K Cells Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) K Cells Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) K Cells Status and Prospect (2013-2023)

1.5 Global Market Size of K Cells (2013-2023)

2 Manufacturers Profiles

2.1 Takeda Pharmaceutical (Japan)

2.1.1 Business Overview

2.1.2 K Cells Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Takeda Pharmaceutical (Japan) K Cells Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sorrento Therapeutics Inc. (USA)

2.2.1 Business Overview

2.2.2 K Cells Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sorrento Therapeutics Inc. (USA) K Cells Revenue, Gross Margin and Market Share (2016-2017)

2.3 NantKwest Inc. (USA)

2.3.1 Business Overview

2.3.2 K Cells Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 NantKwest Inc. (USA) K Cells Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bristol-Myers Squibb (USA)

2.4.1 Business Overview

2.4.2 K Cells Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bristol-Myers Squibb (USA) K Cells Revenue, Gross Margin and Market Share (2016-2017)

2.5 NKT Therapeutics (USA)

2.5.1 Business Overview

2.5.2 K Cells Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 NKT Therapeutics (USA) K Cells Revenue, Gross Margin and Market Share (2016-2017)

3 Global K Cells Market Competition, by Players

3.1 Global K Cells Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 K Cells Players Market Share

3.2.2 Top 10 K Cells Players Market Share

3.3 Market Competition Trend

4 Global K Cells Market Size by Regions

4.1 Global K Cells Revenue and Market Share by Regions

4.2 North America K Cells Revenue and Growth Rate (2013-2018)

4.3 Europe K Cells Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific K Cells Revenue and Growth Rate (2013-2018)

4.5 South America K Cells Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa K Cells Revenue and Growth Rate (2013-2018)

5 North America K Cells Revenue by Countries

5.1 North America K Cells Revenue by Countries (2013-2018)

5.2 USA K Cells Revenue and Growth Rate (2013-2018)

5.3 Canada K Cells Revenue and Growth Rate (2013-2018)

5.4 Mexico K Cells Revenue and Growth Rate (2013-2018)

6 Europe K Cells Revenue by Countries

6.1 Europe K Cells Revenue by Countries (2013-2018)

6.2 Germany K Cells Revenue and Growth Rate (2013-2018)

6.3 UK K Cells Revenue and Growth Rate (2013-2018)

6.4 France K Cells Revenue and Growth Rate (2013-2018)

6.5 Russia K Cells Revenue and Growth Rate (2013-2018)

6.6 Italy K Cells Revenue and Growth Rate (2013-2018)

7 Asia-Pacific K Cells Revenue by Countries

7.1 Asia-Pacific K Cells Revenue by Countries (2013-2018)

7.2 China K Cells Revenue and Growth Rate (2013-2018)

7.3 Japan K Cells Revenue and Growth Rate (2013-2018)

7.4 Korea K Cells Revenue and Growth Rate (2013-2018)

7.5 India K Cells Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia K Cells Revenue and Growth Rate (2013-2018)

8 South America K Cells Revenue by Countries

8.1 South America K Cells Revenue by Countries (2013-2018)

8.2 Brazil K Cells Revenue and Growth Rate (2013-2018)

8.3 Argentina K Cells Revenue and Growth Rate (2013-2018)

8.4 Colombia K Cells Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue K Cells by Countries

9.1 Middle East and Africa K Cells Revenue by Countries (2013-2018)

9.2 Saudi Arabia K Cells Revenue and Growth Rate (2013-2018)

9.3 UAE K Cells Revenue and Growth Rate (2013-2018)

9.4 Egypt K Cells Revenue and Growth Rate (2013-2018)

9.5 Nigeria K Cells Revenue and Growth Rate (2013-2018)

9.6 South Africa K Cells Revenue and Growth Rate (2013-2018)

10 Global K Cells Market Segment by Type

10.1 Global K Cells Revenue and Market Share by Type (2013-2018)

10.2 Global K Cells Market Forecast by Type (2018-2023)

10.3 Mogamulizumab Revenue Growth Rate (2013-2023)

10.4 Lorvotuzumab Mertansine Revenue Growth Rate (2013-2023)

10.5 Others Revenue Growth Rate (2013-2023)

11 Global K Cells Market Segment by Application

11.1 Global K Cells Revenue Market Share by Application (2013-2018)

11.2 K Cells Market Forecast by Application (2018-2023)

11.3 Cancer Revenue Growth (2013-2018)

11.4 Cardiovascular Diseases Revenue Growth (2013-2018)

11.5 Others Revenue Growth (2013-2018)

12 Global K Cells Market Size Forecast (2018-2023)

12.1 Global K Cells Market Size Forecast (2018-2023)

12.2 Global K Cells Market Forecast by Regions (2018-2023)

12.3 North America K Cells Revenue Market Forecast (2018-2023)

12.4 Europe K Cells Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific K Cells Revenue Market Forecast (2018-2023)

12.6 South America K Cells Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa K Cells Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure K Cells Picture

Table Product Specifications of K Cells

Table Global K Cells and Revenue (Million USD) Market Split by Product Type

Figure Global K Cell